Model selection for the move persistence mixed effects model fitted to 22 naïve grey seal pup tracks interpolated at a six-hour time step and estimate move persistence (γ<sub>t</su... by Benia V. R. Nowak (17054285)

Procedure related data, LBNP, LBPP and hypoxia. by Marcus Thudium (6441863)

“…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”

Individual biometric data of patients. by Marcus Thudium (6441863)

“…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”

ADAP deficiency decreases VLA-1 expression in CD8+ T cells with increased amount of H5N1 virus. by Chunyang Li (611137)

Ni causes a decrease in membrane sterols in A549 lung epithelial cells. by Amber R. Matha (19681603)

Genetic interaction of OPRM1 and 5-HT1a. by Jeanette Tour (10790855)

Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

“…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”

Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue. by Wilfredo Oliva-Olivera (301968)

“…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C⁺ and CD163⁺ macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C⁺, CD163⁺: proinflammatory macrophage cell-surface markers.…”

NB5-2 lineage in gnathal segments. by Christof Rickert (4836519)

NB5-6 lineage in gnathal segments. by Christof Rickert (4836519)

NB5-3 lineage in gnathal segments. by Christof Rickert (4836519)

Fig 5 - by Mísia Helena da Silva Ferro (20623666)

Archazolid decreases the activity and expression of cathepsin B in endothelial cells. by Betty Luong (5738027)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

Treatment of serine protease inhibitor (AEBSF) in the uterus decreases the number of sperm in the oviduct. by Shuai Li (65944)

Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus by J. Mwinyi (4002176)

“…Here, we analyzed the plasma sphingoid base profile in a nested group of non-diabetic individuals (N = 605) selected from a population-based study including 5 year follow-up data (CoLaus study). 1-DeoxySLs at baseline were significantly elevated in individuals who developed T2DM during the follow-up (p<0.001), together with increased glucose (p<5.11E-14), triglycerides (p<0.001) and HOMA-IR indices (p<0.001). 1-Deoxy-sphinganine (1-deoxySA) and 1-deoxy-sphingosine (1-deoxySO) were predictive for T2DM, even after adjusting for fasting glucose levels in the binary regression analyses. …”

Fig 5 - by Jeannette Silva-López (16541854)

Knockdown of 1A6/DRIM results in a decrease in 47S rRNA. by Qunhui Peng (358982)

Fig 5 - by Simon Taub (12262035)

A combined algorithm to distinguish between IB and NC models based on the differences in binding kinetics and DynR temporal evolution. by Federico Sevlever (8934533)

“…Predicted <b>DynR</b>(t → 0) according to the value of <i>k</i>₁₀/<i>k</i>₀₁ obtained from Step 2, indicated with a brown horizontal dashed line. …”